The Klinique Med Stock Five Year Return
| KLINIQ Stock | 31.50 0.75 2.44% |
The Klinique Med fundamentals help investors to digest information that contributes to Klinique Med's financial success or failures. It also enables traders to predict the movement of Klinique Stock. The fundamental analysis module provides a way to measure Klinique Med's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Klinique Med stock.
Klinique |
The Klinique Med Company Five Year Return Analysis
Klinique Med's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
| Competition |
According to the company disclosure, The Klinique Med has a Five Year Return of 0.0%. This indicator is about the same for the Consumer Cyclical average (which is currently at 0.0) sector and about the same as Personal Services (which currently averages 0.0) industry. This indicator is about the same for all Thailand stocks average (which is currently at 0.0).
Klinique Five Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Klinique Med's direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Klinique Med could also be used in its relative valuation, which is a method of valuing Klinique Med by comparing valuation metrics of similar companies.Klinique Med is currently under evaluation in five year return category among its peers.
Klinique Fundamentals
| Return On Equity | 0.95 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 9.44 B | |||
| Shares Outstanding | 220 M | |||
| Shares Owned By Insiders | 73.66 % | |||
| Price To Book | 39.18 X | |||
| Price To Sales | 5.73 X | |||
| Revenue | 1.49 B | |||
| Gross Profit | 558.77 M | |||
| EBITDA | 288.81 M | |||
| Book Value Per Share | 0.95 X | |||
| Earnings Per Share | 1.09 X | |||
| Target Price | 44.5 | |||
| Market Capitalization | 7.81 B | |||
| Last Dividend Paid | 0.43 |
About Klinique Med Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze The Klinique Med's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Klinique Med using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of The Klinique Med based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Klinique Stock
Klinique Med financial ratios help investors to determine whether Klinique Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Klinique with respect to the benefits of owning Klinique Med security.